Intensity Therapeutics (INTS) Change in Acquisitions & Divestments (2023 - 2024)
Intensity Therapeutics' (INTS) quarterly Change in Acquisitions & Divestments came in at $3.1 million in Q3 2024, up 1.64% on a QoQ basis from $3.0 million in Q2 2024.
Intensity Therapeutics (INTS) Change in Acquisitions & Divestments (2023 - 2024) Analysis & Trends
Intensity Therapeutics (INTS) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $3.1 million in Q3 2024.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $3.1 million in Q3 2024, while the trailing twelve-month figure through Jun 2025 was $3.1 million (down 79.79% YoY) and the FY2024 annual result came in at $9.4 million, up 4.21% from the prior year.
- Change in Acquisitions & Divestments climbed to $3.1 million in Q3 2024, from $3.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $9.0 million in Q4 2023 to a low of $3.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Intensity Therapeutics | 12.99 Mn | 12.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 3.10 Mn |
| Sep 30, 2024 | 3.10 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 3.26 Mn |
| Mar 31, 2024 | 3.26 Mn |
| Dec 31, 2023 | 9.03 Mn |
| Dec 31, 2023 | 9.03 Mn |